Table 1.

Data from the first cohort of patients.

pathological grade/stage	NMIBC	NMIBC	MIBC	BPH	Controls
	Ta G1–G2 low grade	T1 G1–G2 high grade	T2–T4 high grade
	(n = 10)	(n = 7)	(n = 15)	(n = 7)	(n = 9)
Mean age ± SD	58.1 ± 14.5	72.7 ± 6.1	71.6 ± 6.9	67 ± 0.3	52.7 ± 7.3
Gender (%)
male	8 (80)	7 (100)	14 (93)	7 (100)	6 (67)
female	2 (20)	0 (0)	1 (7)	0 (0)	3 (33)
Carcinoma in situ (CIS) (%)
Yes	1 (10)	3 (43)	2 (13)	0 (0)	0 (0)
No	9 (100)	4 (57)	13 (87)	7 (100)	9 (100)
Node positive (%)
Yes	0 (0)	0 (0)	6 (40)	0 (0)	0 (0)
No	10 (100)	7 (100)	9 (60)	7 (100)	9 (100)
First episode (%)
Yes	8 (80)	5 (71)	15 (100)	7 (100)
No	2 (20)	2 (29)	0 (0)	0 (0)

NMIBC, Non-Muscle Invasive Bladder Cancer; MIBC, Muscle-Invasive Bladder Cancer; BPH, Benign prostatic hyperplasia.